Roivant Sciences (ROIV) Current Deferred Revenue (2021 - 2025)
Roivant Sciences' Current Deferred Revenue was $1.17 million in fiscal Q4 2025 (quarter ended Mar 31, 2025), down 72.0% from $4.17 million a year earlier and down 61.5% from the prior quarter.
Powered by 
Analysis
Roivant Sciences (ROIV) Current Deferred Revenue (2021 - 2025) Analysis & Trends
From fiscal Q4 2021 onward, Roivant Sciences has reported Current Deferred Revenue for 14 quarters.
- Current Deferred Revenue shows a four-year compound annual growth rate of -33.3% (FY2021 to FY2025).
- In earlier fiscal years, Current Deferred Revenue was $4.17 million in FY2024 (-66.5%), $12.44 million in FY2023 (+22.6%), $10.15 million in FY2022 (+71.5%) and $5.92 million in FY2021.
- The fiscal Q4 2025 figure marks the lowest quarterly Current Deferred Revenue in data going back to fiscal Q4 2021.
- Compared with a year earlier, Current Deferred Revenue has declined for seven straight quarters, with an average decline of 42.9% over the last eight quarters.
- The best year-over-year quarter for Current Deferred Revenue over five years was fiscal Q4 2022 (growth of 71.5%); the worst was fiscal Q1 2025 (a decline of 74.8%).
- Per Business Quant data, ROIV's Current Deferred Revenue in the three fiscal quarters before Q4 2025 was $3.04 million (Q3 2025), $3.41 million (Q2 2025) and $2.66 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Roivant Sciences | 26.43 Bn | 27.12 Bn | 1.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 1.17 Mn |
| Dec 31, 2024 | 3.04 Mn |
| Sep 30, 2024 | 3.41 Mn |
| Jun 30, 2024 | 2.66 Mn |
| Mar 31, 2024 | 4.17 Mn |
| Dec 31, 2023 | 4.70 Mn |
| Sep 30, 2023 | 5.80 Mn |
| Jun 30, 2023 | 10.57 Mn |
| Mar 31, 2023 | 12.44 Mn |
| Dec 31, 2022 | 7.80 Mn |
| Sep 30, 2022 | 8.37 Mn |
| Jun 30, 2022 | 9.01 Mn |
| Mar 31, 2022 | 10.15 Mn |
| Mar 31, 2021 | 5.92 Mn |
API Access
Roivant Sciences Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ROIV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "ROIV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ROIV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();